Related Experiment Video

Updated: May 21, 2025

Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia

Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia

Published on: May 6, 2014

The outcome difference of monotherapy versus combination therapy among patients with pneumonia: a systematic review

Pande A Permatananda¹, Pande A Pandit²

¹Department of Pharmacology, Faculty of Medicine and Health Science, Universitas Warmadewa, Bali, Indonesia - nayakasih@gmail.com.

|March 21, 2025

Abstract

Introduction:

Pneumonia is a severe public health problem on a global scale. Pneumonia continues to be the leading infectious disease-related cause of mortality worldwide. Selecting appropriate antimicrobial treatment is a significant challenge including multi-drug resistant bacteria. The use of monotherapy and combination therapy of antibiotics in pneumonia is still controversial. Considering the wide range of patient characteristics and illness severity in pneumonia, it is important to investigate the variables that affect mortality in different treatment plans. Therefore, this study aimed to systematically review the available evidence regarding comparing monotherapy and combination regimens in pneumonia patients.

Evidence Acquisition:

A systematic search across various electronic databases like PubMed, Google Scholar, Proquest, and Cochrane was conducted to identify articles published from 2014 to 2024. Review papers, incomplete articles, and duplicates were excluded.

Evidence Synthesis:

Initially, 179 articles were retrieved from the database search. After a systematic elimination process, sox pertinent articles were identified. These articles involved a total of 11,513 patients across 11 studies. All studies were conducted at single centers, comprising three retrospective cohort studies, one prospective cohort study, one randomized controlled trial, and one cross-sectional study.

Conclusions:

Monotherapy and combination therapy have comparable outcomes in mortality rate and hospital length of stay. However, combination therapy is linked with a lower mortality rate in immunocompromised and APACHE ≥15 patients.

More Related Videos

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

Related Concept Videos

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

Combined Effects of Drugs: Synergism

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...

Pneumonia V: Nursing management and Prevention

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Articles linked to this work by shared authors, journal, and citation graph.

Co-occurrence of sleep disturbances and perceived stress in law enforcement personnel: a systematic review and meta-analysis.

Minerva medica·2026

Pulmonary hypertension in interstitial lung disease: today's realities, tomorrow's possibilities.

Minerva medica·2026

Celiac disease incidence after COVID-19 infection.

Minerva medica·2026

A phase III, randomized, double blind, controlled trial to evaluate the efficacy and safety of a fixed combination of intramuscular diclofenac 75 mg + thiocolchicoside 4 mg, compared to diclofenac 75 mg monotherapy and placebo, in the treatment of acute low back pain.

Minerva medica·2026

Effects of GLP1-RAs and SGLT2i on liver steatosis and fibrosis in MASLD with type 2 diabetes.

Minerva medica·2026

Diagnostic accuracy of the Gugging Swallowing Screen and exploratory submental ultrasonographic findings in dysphagia screening for Parkinson disease: a retrospective cross-sectional study using videofluoroscopy as reference standard.

Minerva medica·2026

See all related articles